TAPUR study

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

TAPUR study
Apr 15, 2025, 13:18 | Blog
Hidehito Horinouchi: Afatinib in patients with solid tumors with neuregulin1 (NRG1) fusions
Hidehito Horinouchi, Assistant Chief at National Cancer Center Hospital, posted on X: "Afatinib in patients…
Jun 6, 2024, 14:04 | Insight
Elie G. Dib: TAPUR study has been presented at the 2024 ASCO Annual Meeting!
Elie G. Dib, Associate Director of the Haematology-Oncology Training Program at Saint Joseph Mercy Hospital,…
May 16, 2024, 14:15 | Insight
Elie G. Dib: Excited to share the results of the TAPUR study
Elie G. Dib, Associate Director of the Haematology-Oncology Training Program at Saint Joseph Mercy Hospital,…
May 6, 2024, 03:39 | Societies
Last call for The TAPUR Study Virtual Grand Rounds - ASCO
ASCO shared on LinkedIn: "Last call! Join us on Monday, May 6, for The TAPUR…
Apr 29, 2024, 20:33 | Blog
Don't miss the TAPUR Study Virtual Grand Rounds on May 6 - American Society of Clinical Oncology (ASCO)
American Society of Clinical Oncology (ASCO) shared on LinkedIn: “"Don't miss the TAPUR Study Virtual Grand…
Apr 27, 2024, 08:10 | Blog
Pam Mangat-Dhaliwal: Join us for a virtual Grand Rounds on May 6, 2024 to learn the latest from the TAPUR Study
Pam Mangat-Dhaliwal, Division Director of Clinical Research and Analytics at ASCO, shared on LinkedIn: “Join…
Apr 24, 2024, 22:25 | Blog
Rachna Shroff: The ASCO TAPUR experience is an incredible story!
Richard Schilsky, Principal Investigator of the American Society of Clinical Oncology TAPUR study, shared a post…
Feb 20, 2024, 18:51 | Blog
Vivek Subbiah: Our editorial comments on the ASCO TAPUR study spearheaded by the amazing Richard Schilsky
Vivek Subbiah recently shared on X/Twitter: "Hot off the press Pleased to share our editorial…
All: 8 Posts: 1 - 100
Special Coverage